Archives

by in
Entry Author Date Location
Alnylam Chief Foresees Another Gene-Silencing Spin-Off, and More News Tidbits from Boston’s MassBio Investors Forum 10/07/09 Boston
Alnylam and Tekmira Seek New Ways to Deliver RNAi Drugs Deep in the Body 08/06/09 Boston
Replacing Phil Sharp Will Be Up to Biogen’s Board 07/20/09 Boston
Novartis Extends Alnylam Deal 07/17/09 Boston
Isis, Alnylam to Collaborate on Single-Stranded RNA Drugs; Deal Could Add Up to $31 Million to Isis’ Coffers 04/29/09 San Diego
Cleaner Water Through Biotech? 349Q Kills Water-Borne Microbes with RNAi 04/27/09 Boston
Alnylam to Receive European Patent 04/20/09 Boston
Traversa Gets $5M 04/02/09 San Diego
Intellectual Ventures Inks India Deal, Ontela Teams with T-Mobile, MDRNA Nabs $7.25M, & More Seattle-Area Deals News 03/24/09 Seattle
Aura Biosciences Aims to Develop “Ballistic Missile” Drug to Beat Pancreatic Cancer, Deliver RNAi Therapies 03/12/09 Boston
Regulus Therapeutics Follows Through on Fundraising, Independence Plans 03/04/09 San Diego
RXi to Sell up to $25M in Stock 02/05/09 Boston
Alnylam, Cubist Will Cooperate on RNAi Drug for Lung Infections 01/09/09 Boston
Another Next-Generation RNAi Startup Emerges, Makes Big Claims About Its Ability to Silence Bad Genes 12/18/08 Boston
Mass Life Sciences Center Attracts J&J Matching Funds, Awards $3.7M in Industry-Academic Grants 12/16/08 Boston
Alnylam Forms UCSF Collaboration 12/11/08 Boston
Alnylam Buys More RNAi Patents From Nucleonics 12/08/08 Boston
Aileron Develops New Class of Drugs To Go Where None Could Before 11/07/08 Boston
Alnylam Hires Chief Scientist, Jack Schmidt, To Help Build RNAi Pipeline 10/01/08 Boston
Alnylam Sees Opportunity in Turning Genes On, And Off 09/05/08 Boston
Hub’s Slice of J&J’s R&D Investment Pie—New Funds from the Medical-Products Giant for Harvard and CIMIT 08/18/08 Boston
Alnylam, Novartis Extend RNA Interference Collaboration 07/16/08 Boston
Alnylam Loses RNAi Patent in Europe; Analyst Says No Worries 07/11/08 Boston
RXi Plans $8.7M Stock Sale 06/24/08 Boston
Alnylam Inks $93M Japanese Deal 06/19/08 Boston
Alnylam Invests $5M in Canadian RNAi Company 06/02/08 Boston
Novartis Increases Stake in Alnylam 05/08/08 Boston
Alnylam Joint Venture Regulus Inks Deal with GSK Worth up to $600 Million 04/17/08 Boston
Mello RNAi Firm RXi Pharmaceuticals Has Wild Ride on First Day of Trading 03/12/08 Boston
Exact Sciences Makes the List, Curis and Alkermes Get Dropped, Patent Reform Sparks Debate, & More Life Sciences News 03/12/08 Boston
Page 3 of 4 « previous page · next page »